Found 244 results
Author [ Title(Asc)] Type Year
Filters: First Letter Of Title is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
N. C. Close, Hering, B. J., Anand, R., and Eggerman, T. L., (Collaborative Islet Transplant Registry [CITR]), Clinical Transplant, vol. Chapter 9, 2004.
N. C. Close, Hering, B. J., Anand, R., and Eggerman, T. L., Collaborative iIslet Transplant Registry, Clin Transpl, pp. 109-18, 2003.
K. Meador, Browning, N., Cohen, M., Kalayjian, L., Liporace, J., Pennell, P., Privitera, M., Kanner, A., and Cantrell, D., Cognitive Outcomes at Two Years Old in Children of Women With Epilepsy Differ As Function of In Utero Antiepileptic Drug, 2006.
T. Clemons, Rankin, M., McBee, W., and Group, A. - R. Eye Diseas, Cognitive Impairment in the Age-Related Eye Disease Study. AREDS Report No. 16, Arch Ophthalmol, vol. 124, pp. 537-543, 2006.
Cognitive Functioning in Children with Renal Failure and Post Transplantation: A Report of the North American Pediatric Cooperative Study (NAPRTCS), in Am Soc of Transpl Phys, Chicago, IL, 1998.
, Cognitive functioning in children with renal failure and post transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS), 1998.
E. Y. Chew, Clemons, T. E., Klein, M. L., Klein, B. E. K., Friberg, T., Bressler, S., and Group, A. - R. Eye Diseas, Cognitive function in the Age-Related Eye Disease Study (AREDS), 2004.
K. J. Meador, Baker, G. A., Browning, B., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, K., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., Cognitive Function at Age 6 Years in Children Exposed In Utero to Antiepileptic Drug, in 65th American Epilepsy Society's Annual Meeting, Baltimore, MD, 2011.
K. Meador, Baker, G., Browning, N., Clayton-Smith, J., Combs-Cantrell, D., Cohen, M., Kalayjian, L., Kanner, A., Liporace, J., Pennell, P., Privitera, M., and Loring, D., Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs, N Engl J Med, vol. 360, pp. 1597-1605, 2009.
L. Sorensen, Neighbors, K., Martz, K., Zelko, F., Bucuvalas, J., and Alonso, E., Cognitive and Academic Outcomes after Pediatric Liver Transplantation: Functional Outcomes Group (FOG) Results, Am J Transplant, vol. 11, no. 2, pp. 303-311, 2011.
W. Ling, Hillhouse, M., Thomas, C., Hasson, A., Annon, J., Mooney, L., Saxon, A., Blumberg, D., Weimer, W., Koosis, E., Brigham, G. S., Woody, G., Trivedi, M., Drexler, K., and Dawes, M., Cocaine Use Reduction with Buprenorphine (CURB): Study Methods and Participant Characteristics, in College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology, Contemp Clin Trials, vol. 34, pp. 196-204, 2013.
J. Kurtzberg, Wagner, E. L., Gindy, L., Issitt, I., Carter, S. L., Kernan, N. A., Jensen, L., Cairo, M. S., and Fraser, J. K., The COBLT Study cord blood banking experience: donor recruitment, collection, processing, testing, and banking, 2001.
E. Karita, Ketter, N., Price, M., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, S., CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.
N. Oden, Van Veldhuisen, P., Scott, I. U., and Ip, M. S., Closed Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study, presented at the 04/2008, St. Louis MO, 2008.
L. - T. Wu, Payne, E. H., Roseman, K., Kinsbury, C., Case, A., Nelson, C., and Lindblad, R., Clinical Workflow and Substance Use Screening, Brief Intervention, and Referral to Treatment Data in the Electronic Health Records: A National Drug Abuse Treatment Clinical Trials Network Study, eGEMs, vol. 7, no. 1, p. 35, 2019.
B. A. Blodi, Ip, M. S., Scott, I. U., Oden, N. L., Van Veldhuisen, P. C., and Warren, K., Clinical vs. Reading Center Baseline Evaluation of Dense Retinal Hemorrhage in the SCORE Branch Retinal Vein Occlusion (BRVO) Study, in Macula Society Annual Meeting, Palm Beach, FL, 2008.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck, Oncology, vol. 14, pp. 553-554559 561, 2000.
T. Davis, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral source. Current clinical trials of the anti- CD20 monoclonal antibody rituximab, Oncology, vol. 14, pp. 14371440-1443, 2000.
P. H. Phillips, Clinical Trials Referral Resource. Trials Using Tumor Vaccines., Oncology, vol. 11, pp. 81-90, 1997.
B. D. Cheson, Phillips, P. H., and Arbuck, S. G., Clinical Trials Referral Resource. Trials of Topotecan., Oncology, vol. 9, no. 3, pp. 220, 224-226, 228, 1995.
A. Murgo, Wood, K. F., Gravell, A. E., and Cheson, B. D., Clinical Trials Referral Resource. STI571, Oncology, vol. 15, no. 7, pp. 881-882, 885-886, 2001.
B. D. Cheson, Arbuck, S. G., and Phillips, P. H., Clinical Trials Referral Resource. Myelodysplastic syndromes., Oncology, vol. 9, no. 9, pp. 821-822, 825, 1995.
B. D. Cheson, Foss, F. M., and Phillips, P. H., Clinical Trials Referral Resource. Mycosis Fungoides/Sézary Syndrome, Oncology, vol. 9, no. 7, pp. 645-646, 1995.
A. P. Nelson, Clinical Trials Referral Resource. Lung cancer., Oncology, vol. 11, pp. 1686-94, 1997.